Ranexa reduces HbA1c, glucose control measures in adults with type 2 diabetes
Healio.com,
BOSTON – The antianginal agent Ranexa may significantly reduce HbA1c levels in addition to providing cardioprotective benefits…
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
Overview of attention for article published in Diabetes Care, June 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (86th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 137 Mendeley